Pages that link to "Q43127396"
Jump to navigation
Jump to search
The following pages link to mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio (Q43127396):
Displaying 14 items.
- Signalling to eIF4E in cancer (Q26777735) (← links)
- Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1 (Q28540038) (← links)
- PI3K and cancer: lessons, challenges and opportunities (Q30080017) (← links)
- Adaptations to chronic rapamycin in mice. (Q36948634) (← links)
- Targeting the translation machinery in cancer (Q38368049) (← links)
- Targeting mTOR for the treatment of B cell malignancies (Q38709825) (← links)
- Catenin delta-1 (CTNND1) phosphorylation controls the mesenchymal to epithelial transition in astrocytic tumors. (Q38752328) (← links)
- Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis (Q41257613) (← links)
- mTORC1 signalling and eIF4E/4E-BP1 translation initiation factor stoichiometry influence recombinant protein productivity from GS-CHOK1 cells. (Q42090149) (← links)
- Immunosuppressants in cancer prevention and therapy (Q42505783) (← links)
- mTOR signaling: new networks for ALL. (Q42743076) (← links)
- The eIF4E2-Directed Hypoxic Cap-Dependent Translation Machinery Reveals Novel Therapeutic Potential for Cancer Treatment (Q47215309) (← links)
- Oncogenic kinases and perturbations in protein synthesis machinery and energetics in neoplasia (Q90721907) (← links)
- TRIBE editing reveals specific mRNA targets of eIF4E-BP in Drosophila and in mammals (Q98772265) (← links)